Los Angeles - 
(NewMediaWire) - November 16, 2021 - The Schall Law Firm, a national shareholder rights litigation
firm, announces the filing of a class action lawsuit against Silverback
Therapeutics, Inc. (“Silverback” or “the Company”) (NASDAQ: SBTX) for violations of the federal securities laws.
Investors who
purchased the Company's shares pursuant and/or traceable to the Company’s
initial public offering conducted on December 3, 2020 (the “IPO”), or between
December 3, 2020 and September 10, 2021, inclusive (the “Class Period”), are
encouraged to contact the firm before January 4, 2022.
If you are a
shareholder who suffered a loss, click here to participate.
We also encourage you
to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite
2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of
charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The class, in this
case, has not yet been certified, and until certification occurs, you are not
represented by an attorney. If you choose to take no action, you can remain an
absent class member.
According to the
Complaint, the Company made false and misleading statements to the market. Silverback’s
product candidate, SBT6050, was not as effective as the Company touted to
investors. The Company materially overstated the product candidate’s clinical
and commercial prospects. Based on these facts, the Company’s public statements
and IPO materials were false and materially misleading throughout the class
period. When the market learned the truth about Silverback, investors suffered
damages.
Join the case to recover your losses.
The Schall Law Firm
represents investors around the world and specializes in securities class
action lawsuits and shareholder rights litigation.
This press release may
be considered Attorney Advertising in some jurisdictions under the applicable
law and rules of ethics.
CONTACT:
The Schall
Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
SOURCE:
The Schall Law Firm
